<!DOCTYPE html>
<html lang="en-US"><head>
		<meta charset="UTF-8">
		<title>FR940223-2-00080</title>
	</head>
	<body>
		<main>
			<p><!-- PJG STAG 4703 -->  <!-- PJG ITAG l=83 g=1 f=1 --> Order <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> For the purposes of this Order: <!-- PJG 0012 frnewline --> 1. ``Competent and reliable scientific evidence'' shall mean tests, analyses, research, studies, or other evidence based on the expertise of professionals in the relevant area that has been conducted and evaluated in an objective manner by persons qualified to do so, using procedures generally accepted by others in the profession to yield accurate and reliable results. <!-- PJG 0012 frnewline --> 2. ``Video advertisement'' shall mean any advertisement intended for dissemination through television broadcast, cablecast, home video, or theatrical release. <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=81 g=1 f=1 --> I <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=3 --> It is ordered, <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 -->  That respondent Thomas L. Fenton, individually and as a former officer and director of Synchronal Corporation and Synchronal Group, Inc., and respondent's agents, representatives and employees, directly or through any partnership, corporation, subsidiary, division or other device, in connection with the advertising, packaging, labeling, promotion, offering for sale, sale or distribution of any product or service in or affecting commerce, as ``commerce'' is defined in the Federal Trade Commission Act, do forthwith cease and desist from selling, broadcasting or otherwise disseminating, or assisting others to sell, broadcast or otherwise disseminate, in part or in while, the program-length television advertisement for Omexin described and identified in the Complaint as ``Can You Beat Baldness?'' <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=81 g=1 f=1 --> II <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=3 --> It is further ordered, <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 -->  That respondent Thomas L. Fenton, individually and as a former officer and director of Synchronal Corporation and Synchronal Group, Inc., and respondent's agents, representatives and employees, directly or through any partnership, corporation, subsidiary, division or other device, do forthwith cease and desist from: <!-- PJG 0012 frnewline --> A. Representing, directly or by implication, in connection with the advertising, packaging, labeling, promotion, offering for sale, sale or distribution of Omexin or any other substantially similar hair loss treatment product or service in or affecting commerce, as ``commerce'' is defined in the Federal Trade Commission Act, that: <!-- PJG 0012 frnewline --> 1. Such product or service contains an ingredient that can or will curtail hair loss for a large majority of balding men and women; <!-- PJG 0012 frnewline --> 2. Such product or service contains an ingredient that can or will promote the growth of significant numbers of new, pigmented terminal hairs where hair has previously been lost for a large majority of men and women; <!-- PJG 0012 frnewline --> 3. Such product or service contains an ingredient that has been scientifically proven to curtail hair loss for a large majority of men and women; <!-- PJG 0012 frnewline --> 4. Such product or service contains an ingredient that has been scientifically proven to promote the growth of new, pigmented terminal hairs where hair has previously been lost for a large majority of men and women; or <!-- PJG 0012 frnewline --> 5. Such product or service has successfully curtailed hair loss and promoted new hair growth for thousands of balding men and women. <!-- PJG 0012 frnewline --> For purposes of this Order a ``substantially similar hair loss treatment product or service'' shall be defined as any product or service that is advertised or intended for sale over-the-counter to treat, cure or curtail hair loss and which contains omentum or any extract thereof. <!-- PJG 0012 frnewline --> B. Representing, directly or by implication, in connection with the advertising, packaging, labeling, promotion, offering for sale, sale or distribution of any other product or service in or affecting commerce, as ``commerce'' is defined in The Federal Trade Commission Act, that: <!-- PJG 0012 frnewline --> 1. The use of the product or service can or will prevent, cure, relieve, reverse, or reduce loss of hair; <!-- PJG 0012 frnewline --> 2. The use of the product or service can or will promote the growth of hair where hair has already been lost; <!-- PJG 0012 frnewline --> 3. The product or service is an effective remedy for hair loss in a substantial number of cases; or <!-- PJG 0012 frnewline --> 4. Any test or study establishes that the product or service relieves, cures, prevents or reverses hair loss, <!-- PJG /ITAG -->  <!-- PJG QTAG 02 --> <!-- PJG /QTAG -->  <!-- PJG 0012 frnewline -->  <!-- PJG ITAG l=10 g=1 f=1 --> unless such representation is true and unless, at the time of making such representation, respondent possesses and relies upon competent and reliable scientific evidence that substantiates the representation. <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> C. Advertising, packaging, labeling, promoting, offering for sale, selling, or distributing any product that is represented as promoting hair growth or preventing hair loss, unless the product is the subject of an approved new drug application for such purpose under the Federal Food, Drug, and Cosmetic Act, 21 U.S.C. 301  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=3 --> et seq., provided that, <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 -->  this subpart shall not limit the requirements of Part II.A and B herein. <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG /STAG --></p>
		</main>
</body></html>
            